A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Calculations

Author(s):  Stockton Shelly J

Issue:  Jan/Feb 2015 - Volume 19, Number 1
View All Articles in Issue

Page(s):  59

Related Articles from IJPC
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Does Your Drug Expertise Include Clinical Pharmaceutics? Newton David W	May/Jun 2016 Pg. 202-206
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Jasti Bhaskara R, Saraf Poonam	May/Jun 2011 Pg. 259-261
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr	Mar/Apr 2011 Pg. 92
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 294-298
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
The Role of Compounding Pharmacists During Drug Shortages Ofei Kelvin	Jul/Aug 2022 Pg. 298-301
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun	Mar/Apr 2018 Pg. 108-121
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 350-351
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Kramer Mark A, Grilley Bambi J	Jul/Aug 2002 Pg. 271-273
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Stephenson Kenna, Jones William, Stephenson Douglas M M	May/Jun 2006 Pg. 175-183
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015 Pg. 377-380
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
PreScription: Factors Related to Drug Waste and Pharmacy Solutions Allen Loyd V Jr	Jul/Aug 2018 Pg. 268
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
Return to Top